This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEI8J12S_L.jpg
West Virginia had been prepared to proceed to trial on Sept. 26 against those two companies and Walgreens Boots Alliance (NASDAQ:WBA).
The state had accused the pharmacy chains of fueling the deadly opioid epidemic through their allegedly lax oversight of prescription pills sold in the state.
Walgreens has not settled, and a trial has been rescheduled for June 2023.
“We believe that we have a very strong case against Walgreens,” Morrisey said at a news conference. “We’re going to pursue that quite vigorously.”
The state has been particularly hard hit by the epidemic, with a per capita opioid mortality rate over three times the national average in 2020, according to data from the National Center for Health Statistics.
